InVivoMAb Anti-Human IFN-gamma (TBS10308)

$489.00$2,399.00

Target: Interferon gamma, IFN-gamma, Immune interferon, IFNG, IFN-γ.

SKU: TBS10308 Categories: ,
SKUStock SIZE (mg) PriceQuantity
TBS10308-0.5MG Yes 0.5 MG $489.00
spinner
TBS10308-1MG Yes 1 MG $719.00
spinner
TBS10308-5MG Yes 5 MG $2,399.00
spinner

Description

InVivoMAb Anti-Human IFNG/IFN-gamma is a humanized monoclonal antibody that neutralizes interferon-gamma (IFN-γ), a key cytokine in inflammatory pathways. IFN-γ, produced mainly by T cells and NK cells, regulates immune responses by activating Th1 cells, monocytes, and macrophages, enhancing antigen presentation, and influencing B cell antibody class. It also has antiviral, antiproliferative, and immunomodulatory effects. In autoimmune diseases such as Crohn’s disease.

Synonyms: Anti-Human IFNG antibody, Anti-IFN-γ antibody, neutralizing anti-IFN-gamma monoclonal antibody, Human IFN-gamma blocking antibody, IFN-γ neutralizing antibody (human).

Product Details

Applications: ELISA, Neutralization, Flow Cytometry (FCM).
Species Reactivity: Human
Host: Human
Isotype: IgG1
Target: Interferon gamma, IFN-gamma, Immune interferon, IFNG, IFN-γ.
Uniprot: P01579
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage Buffer: 0.01 M PBS, pH 7.4.
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: –20°C for 12 months; –80°C for long-term; avoid repeated freeze-thaw cycles.

Data Image

Fig. 1. SDS-PAGE analysis of InVivoMAb Anti-Human IFN-γ

MW: Molecular Weight (kDa) Marker

R: Reducing conditions; NR: Non-Reducing conditions

Fig. 2. Bioactivity and target binding of Anti-Human IFN-γ

    

Fig. 3 FITC fluorescence intensity of IFN-γ  

 

 Fig. 4 APC fluorescence intensity of IFN-γ

Research use only.

Additional information

SIZE (mg)

1 MG, 5 MG, 0.5 MG

Reviews

There are no reviews yet.


Be the first to review “InVivoMAb Anti-Human IFN-gamma (TBS10308)”